Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal
Patent
1984-10-22
1986-04-15
Kight, John
Chemistry of carbon compounds
Miscellaneous organic carbon compounds
C-metal
514773, 514801, 128DIG8, C08L 8906, A61L 1504
Patent
active
045826404
ABSTRACT:
Cross-linked atelopeptide collagen that is substantially free of residual cross-linking agent is prepared by: reconstituting atelopeptide collagen from solution by neutralizing the solution at a reduced temperature and a hypotonic ionic strength; cross-linking the reconstituted fibers in an aqueous medium at a concentration of 0.1 to 10 mg/ml with glutaraldehyde under conditions that produce cross-linked collagen that when in suspension in physiological saline at a concentration of 35 mg/ml exhibits a shear viscosity whose log varies linearly with the log of the shear rate and is approximated by the formula
REFERENCES:
patent: 3949073 (1976-04-01), Daniels et al.
patent: 4140537 (1979-02-01), Luck et al.
patent: 4233360 (1980-11-01), Luck et al.
patent: 4424208 (1984-01-01), Wallace et al.
Schechter, I., et al, "Prolonged Retention of Glutaraldehyde-Treated Skin Homografts in Humans", Brit. Journal of Plas. Surg., (1975) 28, 198-202.
McPherson John
Smestad Thomas L.
Wallace Donald G.
Collagen Corporation
Kight John
Nutter Nathan M.
LandOfFree
Injectable cross-linked collagen implant material does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Injectable cross-linked collagen implant material, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable cross-linked collagen implant material will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1437579